News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
GlaxoSmithKline Malaria Vaccine Works For 15 Months: Study
January 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- GlaxoSmithKline Plc’s experimental malaria vaccine, already shown to cut the risk of children contracting the disease by half after 8 months, was equally effective after 15, a study showed.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
GSK
MORE ON THIS TOPIC
Sponsored by AGC Biologics
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
September 21, 2026
·
7 min read
·
AGC Biologics
IPO
Electra lights up with $350M IPO for pivotal immune-disease drug development
September 18, 2026
·
1 min read
·
Gabrielle Masson
Neuropsychiatric disorders
Xenon tumbles on voluntary psychiatry hold, but analysts confident in $2B epilepsy opportunity
September 18, 2026
·
4 min read
·
Annalee Armstrong
Cancer
BMS scraps Orum’s targeted degrader after reviewing Phase 1 data
September 18, 2026
·
1 min read
·
Tristan Manalac
